Analyst Ratings for Benitec BioPharma (BNTC)
BNTC Rating Summary
BNTC Price Target Summary
- Highest: $32.00 (H.C. Wainwright)
- Lowest: $16.00 (Wedbush)
- Average: $26.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$26.00 (+118.7%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 79%
Avg. $ Target:
$26.00 (+118.7%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 79%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/28/2026 | Wedbush | Yun Zhong | New Coverage | Outperform (N/A) |
16.00 (N/A) |
11.58 (11.89) |
2.68% | Details |
| 6/10/2026 | Guggenheim | Debjit Chattopadhyay | Downgrade | Neutral (Buy) |
N/A (N/A) |
10.81 (11.89) |
9.99% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
